Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Chengji Pharmaceutical is a comprehensive pharmaceutical enterprise based in Beijing, China, specializing in the research, development, production, and sale of chemical drug preparations and active pharmaceutical ingredients (APIs). The company maintains a diverse product portfolio that addresses critical needs in therapeutic areas such as respiratory health, gastroenterology, anti-infectives, and cardiovascular diseases. Key commercial products include Ambroxol Hydrochloride for respiratory conditions and proton pump inhibitors like Omeprazole and Pantoprazole for digestive disorders. Chengji Pharmaceutical operates modern, GMP-certified manufacturing facilities capable of producing various dosage forms, including large and small volume injections, tablets, and capsules. The company is recognized as a high-tech enterprise in China, focusing on providing high-quality generic medications and improving healthcare accessibility.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 北京诚济制药.